Sinopharm (000028.SZ) released results for the first three quarters, with net profit of 952 million yuan to mother, a year-on-year decrease of 0.48%

According to the Zhitong Finance App, Sinopharm (000028.SZ) released a report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 55.066 billion yuan, a year-on-year decrease of 0.11%. Net profit attributable to shareholders of listed companies was 952 million yuan, a year-on-year decrease of 0.48%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was $945 million, an increase of 2.36% over the previous year.